Exousia Pro Creates New Subdivisions
Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new...
Pharmaceutical
Medical Care Technologies Inc. (OTC PINK:MDCE) Launches AI Wound Monitoring Tool for $20+ Billion Chronic Care Market
MESA, ARIZONA / ACCESS Newswire / September 3, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced its AI-powered...
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS...
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
Onvida Health and Ambience Healthcare Launch Frontier Ambient AI Capabilities Inside Epic
Ambience's seamless integration with Epic's EHR improves patient experience, reduces burden for clinicians, and strengthens compliance for health system SAN...
ACOFP Foundation’s Family Medicine Forward Campaign Funds Expanded Programs for Early Career Physicians
Campaign Supports Mentorship and Expanded Leadership Training CHICAGO, IL / ACCESS Newswire / September 3, 2025 / The American College...
PSF Dental Reinforces Market Leadership With High-Quality Dental Equipment at Unbeatable Prices
SINGAPORE, SG / ACCESS Newswire / September 3, 2025 / PSF Dental, a trusted global supplier of innovative dental solutions,...
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company...
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker...
“Ozempi-Tuck”: Dr. Joshua Hyman’s Tummy Tuck Solution for Patients After Rapid Weight Loss
Sculpting New Confidence: Dr. Hyman's Tummy Tuck for GLP-1 Driven Weight Loss NEW YORK CITY, NY / ACCESS Newswire /...
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and...
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading...
Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACS Consistent Improvements in Weight Gain,...
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the...
Journey Medical Corporation to Participate in September 2025 Investor Conferences
SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming...
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025
THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced data from a study of...
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA...
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
Cryptocurrency treasury reserve strategy is designed to diversify capital structure while reinforcing CDT's innovation-led modelNAPLES, Fla. and CAMBRIDGE, United Kingdom,...